DK0546547T3 - Farmaceutisk præparat til forbedring af dysuri - Google Patents

Farmaceutisk præparat til forbedring af dysuri

Info

Publication number
DK0546547T3
DK0546547T3 DK92121075.3T DK92121075T DK0546547T3 DK 0546547 T3 DK0546547 T3 DK 0546547T3 DK 92121075 T DK92121075 T DK 92121075T DK 0546547 T3 DK0546547 T3 DK 0546547T3
Authority
DK
Denmark
Prior art keywords
denotes
carbon atoms
alkyl group
group
dysuria
Prior art date
Application number
DK92121075.3T
Other languages
Danish (da)
English (en)
Inventor
Yuko Morioka
Mitsuru Takano
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of DK0546547T3 publication Critical patent/DK0546547T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK92121075.3T 1991-12-10 1992-12-10 Farmaceutisk præparat til forbedring af dysuri DK0546547T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3325458A JP2549480B2 (ja) 1991-12-10 1991-12-10 排尿障害改善剤

Publications (1)

Publication Number Publication Date
DK0546547T3 true DK0546547T3 (da) 1995-02-13

Family

ID=18177097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92121075.3T DK0546547T3 (da) 1991-12-10 1992-12-10 Farmaceutisk præparat til forbedring af dysuri

Country Status (18)

Country Link
US (1) US5496823A (cs)
EP (1) EP0546547B1 (cs)
JP (1) JP2549480B2 (cs)
KR (1) KR930012019A (cs)
CN (1) CN1073861A (cs)
AT (1) ATE110569T1 (cs)
AU (1) AU656443B2 (cs)
CA (1) CA2084962A1 (cs)
CZ (1) CZ282422B6 (cs)
DE (1) DE69200365T2 (cs)
DK (1) DK0546547T3 (cs)
ES (1) ES2062860T3 (cs)
HU (2) HUT63055A (cs)
IL (1) IL104026A (cs)
MX (1) MX9207123A (cs)
PH (1) PH30691A (cs)
TW (1) TW210286B (cs)
ZA (1) ZA929529B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
DE19529102A1 (de) * 1995-08-08 1997-02-13 Kummer Horst Dieter Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen
EP0927034A1 (en) * 1996-09-19 1999-07-07 American Home Products Corporation Method of treating urinary incontinence
WO2020186187A1 (en) * 2019-03-13 2020-09-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for treating bladder and urethra dysfunction and disease
BR112022004441A2 (pt) 2019-10-02 2022-06-07 Aska Pharm Co Ltd Agente para melhorar distúrbio de micção
WO2021065027A1 (ja) 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤
EP4265258A4 (en) 2020-12-18 2024-11-13 ASKA Pharmaceutical Co., Ltd. FIXED FORMULATION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
DE69200365D1 (de) 1994-10-06
JPH05155773A (ja) 1993-06-22
ES2062860T3 (es) 1994-12-16
MX9207123A (es) 1993-07-30
PH30691A (en) 1997-09-16
IL104026A (en) 1995-11-27
AU2998592A (en) 1993-06-17
CN1073861A (zh) 1993-07-07
TW210286B (cs) 1993-08-01
CZ361192A3 (en) 1993-09-15
HUT63055A (en) 1993-07-28
US5496823A (en) 1996-03-05
KR930012019A (ko) 1993-07-20
DE69200365T2 (de) 1995-02-16
HU9203911D0 (en) 1993-03-29
JP2549480B2 (ja) 1996-10-30
CA2084962A1 (en) 1993-06-11
AU656443B2 (en) 1995-02-02
ATE110569T1 (de) 1994-09-15
CZ282422B6 (cs) 1997-07-16
EP0546547B1 (en) 1994-08-31
IL104026A0 (en) 1993-05-13
ZA929529B (en) 1993-06-15
EP0546547A1 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
ATE174899T1 (de) Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen
IT1314184B1 (it) Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
IL144170A0 (en) 4-oxo-1,4-dihydro-3-quinolinecarboamides as antiviral agents
HK85984A (en) Nasal pharmaceutical compositions
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
IE800327L (en) N-substituted aziridine-2-carboxylic acid derivatives
ES8200011A1 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
DK0665834T3 (da) Quinolon- og acridinonderivater til behandling af urininkontinens
DK0546547T3 (da) Farmaceutisk præparat til forbedring af dysuri
CA2220024A1 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
DK0528164T3 (da) Anvendelse af xanthinderivater til fremstilling af et lægemiddel til behandling af sekundære nervecelleskader og funktionsforstyrrelser efter kranie-hjerne-traumer
TW223016B (cs)
ES2093091T3 (es) Derivado de glutation.
IT1147330B (it) Medicamento,o preparato farmaceutico,ad azione citostatica
AU544275B2 (en) Triazololozuinazolinone derivatives
AU2224795A (en) Ameliorant or remedy for paraneoplastic syndrome
ES2073868T3 (es) Una composicion profilactica/terapeutica para la pleuroneumonia del cerdo.
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
TW360630B (en) A secoaporphine compounds on arrhythmia
RU92004490A (ru) Фармацевтическая композиция для лечения дизурии и способ ее лечения